admin

Airtel injects 1 billion dollars into Nxtra, major deals span copper, rail, energy storage, pharma and finance, MakeMyTrip hit by short seller report

Novo Nordisk on Tuesday cut the prices of its diabetes and weight-loss drugs Ozempic and Wegovy by as much as 36% and 48% in India, its second such move, to fend off competition from local drugmakers’ cheaper generics.

Zetwerk files confidential IPO papers aiming to raise up to $550 million at $4 billion valuation, plans listing this year with 300 million in fresh equity

Barclays urges defensive stocks amid market volatility, highlighting Extra Space Storage, JPMorgan, Coca Cola and Merck for dividends and potential upside

Granules India unit gets USFDA VAI rating for Telangana plant after Dec 2025 inspection, no regulatory action, boosting multi site production, shares down slightly

Lupin gets USFDA tentative nod for Sugammadex Injection, a generic of Bridion for reversing surgical muscle relaxants, can launch in US after final approval and exclusivity expiry

Texmaco Rail wins ₹357.11 crore JSW order to supply wagons and rakes in 11 months, adding to its rail freight order book, shares remain sharply down over recent months

IHC to become promoter of Sammaan Capital via $1 billion deal, stake may rise to 63.3%, funding expansion into diversified lending and growth in India

Jignanshu Gor, Director & Senior Research Analyst at Bernstein, remains positive on Avenue Supermarts (DMart), Titan and Trent but cautions that broader consumption demand is uncertain amid rising inflation, even as valuations look attractive.

Mihir Vora, CIO of Trust Mutual Fund, explains why the current market environment is different from past crises, with physical supply disruptions in oil and gas driving uncertainty. He highlights that the duration of the crisis will matter more than…